Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 6/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | PNKP | Q96T60 | 1/20 | 0.31 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11787706 | 0.89 | SMN1; SMN2 (0.43) | SMN1; SMN2MAPK1MAPTALDH1A1LMNA | |
| SCHEMBL8680930 | 0.88 | MAPT (0.38) | SMN1; SMN2MAPK1MAPTALDH1A1LMNA | |
| SCHEMBL13284919 | 0.85 | SMN1; SMN2 (0.35) | SMN1; SMN2MAPK1MAPTLMNAMEN1 | |
| SCHEMBL12109887 | 0.83 | NPSR1 (0.31) | SMN1; SMN2MAPTLMNAMEN1KMT2A | |
| SCHEMBL12109892 | 0.83 | MEN1 (0.46) | SMN1; SMN2MAPK1MAPTLMNAMEN1 | |
| SCHEMBL12111146 | 0.83 | GAA (0.34) | SMN1; SMN2MAPTLMNAMEN1KMT2A | |
| SCHEMBL29473569 | 0.78 | MAPT (0.50) | SMN1; SMN2MAPK1MAPTALDH1A1LMNA | |
| SCHEMBL13326515 | 0.78 | MAPT (0.50) | SMN1; SMN2MAPK1MAPTALDH1A1LMNA | |
| SCHEMBL30612732 | 0.78 | MAPT (0.50) | SMN1; SMN2MAPK1MAPTALDH1A1LMNA | |
| SCHEMBL976219 | 0.78 | MAPT (0.50) | SMN1; SMN2MAPK1MAPTALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110297898-A1 | PREPARATION OF A PHOTOCHROMIC INK | BASF SE (DE) | 2011-12-08 | — | — | US | disclosed |
| US-20110269242-A1 | TIME TEMPERATURE INDICATOR COMPRISING INDOLENIN BASED SPIROPYRANS | BASF SE (DE) | 2011-11-03 | — | — | US | disclosed |
| US-20110269242-A1 | TIME TEMPERATURE INDICATOR COMPRISING INDOLENIN BASED SPIROPYRANS | BASF SE (DE) | 2011-11-03 | — | — | US | disclosed |
| WO-2010079114-A1 | TIME TEMPERATURE INDICATOR COMPRISING INDOLENIN BASED SPIROPYRANS | BASF SE (DE) | 2010-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269242-A1 | TIME TEMPERATURE INDICATOR COMPRISING INDOLENIN BASED SPIROPYRANS | TTN, CCNI, TPH1 | SMN1; SMN2 3869/4885MAPK1 2197/4885MAPT 90/4885 |
| US-20110297898-A1 | PREPARATION OF A PHOTOCHROMIC INK | RB1, REN, MYH14 | SMN1; SMN2 1844/4885MAPK1 1806/4885MAPT 1266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.